A Common Technology Leadership Hire Biotech Companies Make at the Wrong Stage

There is a hiring pattern I see in biotech that creates friction, even when the person hired is experienced and capable.

On paper, the hire makes complete sense. The person has held the title before. They have worked in impressive organizations. They have led teams. They understand systems.

There’s no obvious red flag.

But a few months in, something feels off.

Execution feels slower than expected. The leader feels constrained. The organization feels frustrated. Conversations shift from excitement to quiet questions.

In most of these situations, the issue isn’t competence.

It’s stage.

And I see this more often than people realize.

Technology leadership roles are not interchangeable across biotech companies. The environment matters. The operating model matters. The way decisions are made matters.

When someone who is optimized for one stage joins a company operating in a very different stage, friction is natural.

That doesn’t mean anyone made a careless decision.

It usually means alignment wasn’t examined closely enough.

Stability Sounds Good Until It Isn’t

I recently spoke with a technology leader who had been working in a smaller, fast-moving company. He described the environment as unstable. Priorities shifted constantly. Resources were tight. Decisions were made quickly because they had to be.

In that setting, if something needed to change, it changed that day.

No long approval chains. No committees. No waiting for next quarter.

Speed wasn’t optional. It was survival.

Over time, that pace wore on him. He decided he wanted stability. More structure. Fewer surprises.

So he joined a much larger organization.

On paper, it offered exactly what he thought he wanted: established systems, defined processes, formal governance.

A few months into the role, he said to me,
“I’m falling asleep. Stuff takes forever. I’ve got to get it through approval processes. I have to apply to apply for a change. Nothing just happens.”

What he was describing wasn’t dysfunction.

It was scale.

Larger biotech organizations operate differently because they have to. As companies grow, more stakeholders are involved. More oversight is required. Regulatory weight increases. Decisions that were once made by one person now require coordination across functions.

That’s not inefficiency.

That’s just what happens when companies grow.

The company wasn’t wrong.

He wasn’t wrong.

He was simply optimized for a different environment.

Small Biotech and Large Biotech Are Different Jobs

One of the biggest misconceptions I encounter is the assumption that a CTO or CIO role is the same regardless of company size.

It isn’t.

In a smaller biotech, the technology leader is deeply integrated into the business. The role isn’t just oversight. It’s building systems, working directly with vendors, partnering with functional leaders, and solving immediate problems.

Strategy and execution blend together.

You might be discussing long-term architecture in the morning and troubleshooting a system issue in the afternoon.

In those environments, every hire represents a meaningful percentage of operating capacity. Cultural fit matters immediately. Pace matters immediately. If someone doesn’t mesh with the team or the tempo, everyone feels it.

Flexibility isn’t optional. Ambiguity is constant.

By contrast, larger biotech organizations operate within established structures. Governance frameworks exist. Compliance protocols are defined. Approval pathways are formal.

Changes move through coordination points. Risk is evaluated. Stakeholders weigh in.

I once placed a professional who moved from a lightly regulated environment into a large medical device company. She described the contrast clearly.

At her previous company, she would come back from lunch to find notes outlining changes that needed to be made. She would simply implement them.

In her new role, she needed to speak with multiple people before making even a small adjustment. Approvals. Documentation. Alignment.

That wasn’t inefficiency.

It was the operating reality of a more mature organization.

The title was the same.

The job was not.

Builders and Structured Operators

There is also a real difference between leaders who are wired to build and those who are wired to operate within established systems.

Some leaders thrive in ambiguity. They’re comfortable creating process where none exists. They move quickly. They make decisions with incomplete data and adjust as they go.

Others excel within structure. They navigate governance well. They manage complexity across stakeholders. They bring discipline to process and alignment.

Neither profile is better.

But they are suited to different conditions.

If a company that needs speed hires someone most comfortable inside layered approval structures, progress can feel slow.

If a mature organization hires someone expecting full autonomy, friction can surface just as quickly.

It’s not about intelligence.

It’s about context.

Decision-Making Reflects Stage

Stage shows up most clearly in how decisions get made.

In smaller biotech environments, decisive leadership is often necessary. Resources are limited. Time matters. Too much consensus can stall progress.

I often say, if everyone’s leading, no one’s leading.

In early-stage settings, someone has to set direction and move.

As organizations grow, however, risk increases. Regulatory exposure increases. Stakeholders multiply. Governance structures formalize.

Alignment becomes necessary because the cost of error becomes higher.

When a leader wired for speed enters a system built for coordination, frustration develops.

When a leader accustomed to layered governance enters an environment that needs rapid action, tension appears on the other side.

Neither model is broken.

They’re built for different realities.

The Real Cost of Getting Stage Wrong

When stage alignment is overlooked, the consequences don’t always show up immediately.

At first, it feels like friction.

Then execution slows.

Then priorities start shifting.

And eventually, the company realizes something bigger: the direction isn’t working.

I’ve seen situations where systems get partially rebuilt because the original leader designed for scale that didn’t exist yet. Or the opposite — infrastructure built for speed that couldn’t handle regulatory complexity.

When that happens, it’s not just uncomfortable.

It’s expensive.

Search fees. Transition time. Rework. Lost momentum. Sometimes even leadership turnover.

In biotech, where runway matters and milestones matter, losing six to twelve months because of stage misalignment is not a small issue.

It’s a reset.

And most of the time, it could have been avoided with clearer upfront alignment around what stage the company is actually operating in.

Alignment Matters More Than Title

When hiring a CTO, CIO, or senior technology leader, the most important question isn’t whether they’ve held the title before.

The better question is whether they’ve operated successfully in an environment that mirrors your current stage.

Are you building from scratch?

Are you operating within heavy governance?

Do you need speed?

Or disciplined coordination?

Stage defines the job more than the title does.

A leader who thrives in structure may struggle in ambiguity.

A leader who excels in fast-moving environments may struggle where every change requires formal approval.

That’s not a talent issue.

It’s a stage issue.

And in biotech, where regulatory requirements and operating models vary widely, understanding your stage before making a leadership hire can prevent unnecessary friction later.

The right leader for one stage may not be the right leader for another.

That doesn’t diminish their capability.

It simply acknowledges something too many companies overlook:

Context matters.

 

About The Author:

Steve Swan is a technology recruiter focused on the biotech and life sciences sector. He partners with growing and established biotech companies to identify senior technology leaders who align with the organization’s stage, culture, and operating model. With a practical understanding of how IT strategy intersects with business execution, Steve helps companies avoid costly leadership mismatches and build teams that move at the right speed for where they are.

Are you looking for top IT talent in the pharmaceutical or biotech industry?

Contact us to discuss how we can bring top-tier IT talent to your organization. The Swan Group are executive leaders with extensive IT recruiting expertise in the biotech and pharmaceutical space. Our goal is to ensure that each professional we place and each client we work with achieves a competitive advantage based upon our services.

Are you a professional looking for a new opportunity?

Contact us to discuss your career options or browse our opportunities. As a small boutique firm, we are in the business of building careers, not just filling positions.

ABOUT THE SWAN GROUP

Our goal is to ensure that each professional we place and each client we work with achieves a competitive advantage based upon our services. Our specialty is high-level INFORMATION TECHNOLOGY placement within the Pharmaceutical, Bio-Pharmaceutical, and Consumer Products industries. Thoughts, comments, or would like to discuss further, please contact us.